Reckitt Benckiser discontinues Suboxone Tablets
Reckitt Benckiser Pharmaceuticals Inc. has issued a Citizen Petition with the Food and Drug Administration requesting action to curtail the risk of pediatric exposure with buprenorphine-containing products for the treatment of opioid dependence.